Business / Finance

RSS

Asahi Kasei to acquire ZOLL

Asahi Kasei Corporation, and ZOLL Medical Corporation today jointly announced that Asahi Kasei, Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion.

12 Mar 2012

AMGA honors Abbott with Distinguished Corporate Partner Award

The American Medical Group Association (AMGA) announced today that it will present the AMGA Distinguished Corporate Partner Award on March 10 to Abbott Laboratories at its 2012 Annual Conference, March 8-10 at the Manchester Grand Hyatt.

12 Mar 2012

4th quarter hospital revenues increase

Spending at hospitals surged in the fourth quarter, government data showed on Thursday, suggesting economic growth during that period could be revised significantly higher.

10 Mar 2012

Emergent BioSolutions fourth quarter total revenues increase to $107.9M

Emergent BioSolutions Inc. announced today its financial results for the fourth quarter and full year ended December 31, 2011.

9 Mar 2012

3SBio fourth quarter total net revenues increase 38.2% to RMB139.9M

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced its unaudited financial results for the fourth quarter and full year ended December 31, 2011.

9 Mar 2012

Maxygen reports net loss of $2.2 million for fourth quarter 2011

Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.

9 Mar 2012

AMN consolidated revenue increases 32% to $887M for full year 2011

AMN Healthcare Services, Inc., the nation's innovator in healthcare workforce solutions, today announced financial results for the full year and fourth quarter 2011. The results were at the upper end of management's expectations, the Company said.

9 Mar 2012

Boston Scientific exercises option to acquire Cameron Health

Boston Scientific Corporation announces the exercise of its option to acquire Cameron Health, Inc., a privately held company based in San Clemente, California.

9 Mar 2012

GenMark Diagnostics fourth quarter revenues increase to $2.0M

GenMark Diagnostics, Inc. today reported preliminary financial results for the fourth quarter and fiscal year ended December 31, 2011. The Company will release its full financial statements and related disclosures along with its Form 10-K filing for the period ending December 31, 2011 upon completion of its independent audit, which includes the Company's first Sarbanes-Oxley audit of internal controls, by March 15, 2012.

9 Mar 2012

PharmAthene revenue increases to $24.3M for year ended December 31, 2011

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial and operational results for the year ended December 31, 2011.

9 Mar 2012

CHS prices $1.0 billion senior notes offering

Community Health Systems, Inc., announced today that on March 7, 2012, its wholly-owned subsidiary, CHS/Community Health Systems, Inc., priced an offering of $1.0 billion aggregate principal amount 8.00% senior notes due 2019 at an issue price of approximately 102.5%.

9 Mar 2012

U.S. Physical Therapy fourth quarter net revenues increase 13.8% to $60,678,000

U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, today reported results for the fourth quarter and year ended December 31, 2011.

9 Mar 2012

PhotoMedex fourth quarter revenues increase 26% to $28.8M

PhotoMedex, Inc. today reported financial results for the three and 12 months ended December 31, 2011.

9 Mar 2012

Unigene fourth quarter net income increases to $4.4 million

Unigene Laboratories, Inc., today announced financial results for the fourth quarter and full-year ended December 31, 2011.

9 Mar 2012

Celgene acquires Avila Therapeutics

Celgene Corporation today announced it has completed its acquisition of Avila Therapeutics. Celgene acquired Avila Therapeutics for $350 million in cash, plus up to $575 million contingent upon certain milestones related to AVL-292 and candidates from Avila's discovery program.

9 Mar 2012

Omega Protein fourth quarter revenues increase 46% to $62.8M

Omega Protein Corporation, a nutritional ingredient company and the nation's leading vertically integrated producer of omega-3 fish oil and specialty fish meal products, today reported financial results for the fourth quarter and full year ended December 31, 2011.

8 Mar 2012